Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'

The iShares Biotechnology ETF IBB, which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%.

On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks.

Check out other stocks making moves in the premarket.

Steven Grasso of Grasso Global said that Meta Platforms Inc’s META stock bounced and “it is still going.”

Courtney Garcia of Payne Capital Management chose Taiwan Semiconductor Mfg. Co. Ltd. TSM. “I like emerging markets here,” she added.

Tim Seymour of Seymour Asset Management said Las Vegas Sands Corp. LVS is another China play that is worth checking.

Photo via Shutterstock.